NewEdge Advisors LLC Has $637,000 Stock Position in ARK Genomic Revolution ETF $ARKG

NewEdge Advisors LLC increased its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 102.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 24,092 shares of the company’s stock after buying an additional 12,202 shares during the period. NewEdge Advisors LLC owned 0.05% of ARK Genomic Revolution ETF worth $637,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. JPMorgan Chase & Co. boosted its holdings in ARK Genomic Revolution ETF by 30.6% during the fourth quarter. JPMorgan Chase & Co. now owns 5,149,454 shares of the company’s stock valued at $149,180,000 after acquiring an additional 1,205,541 shares during the period. Morgan Stanley increased its stake in shares of ARK Genomic Revolution ETF by 42.2% in the fourth quarter. Morgan Stanley now owns 4,025,965 shares of the company’s stock worth $116,632,000 after purchasing an additional 1,193,795 shares during the period. BNP Paribas Financial Markets lifted its position in shares of ARK Genomic Revolution ETF by 49.7% during the 4th quarter. BNP Paribas Financial Markets now owns 3,514,980 shares of the company’s stock worth $101,829,000 after purchasing an additional 1,167,558 shares during the last quarter. Wells Fargo & Company MN boosted its stake in ARK Genomic Revolution ETF by 29.1% during the 4th quarter. Wells Fargo & Company MN now owns 1,287,390 shares of the company’s stock valued at $37,296,000 after purchasing an additional 290,301 shares during the period. Finally, LPL Financial LLC boosted its stake in ARK Genomic Revolution ETF by 9.0% during the 4th quarter. LPL Financial LLC now owns 824,961 shares of the company’s stock valued at $23,899,000 after purchasing an additional 68,267 shares during the period.

ARK Genomic Revolution ETF Stock Down 0.2%

ARKG opened at $47.64 on Friday. The stock’s 50 day moving average price is $40.52 and its two-hundred day moving average price is $33.29. ARK Genomic Revolution ETF has a 12-month low of $23.75 and a 12-month high of $48.88.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.